212 related articles for article (PubMed ID: 8414505)
21. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
Guerin C; Luddy C; Abounader R; Lal B; Laterra J
Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
[TBL] [Abstract][Full Text] [Related]
22. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
23. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
Seol DW; Chen Q; Zarnegar R
Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
[TBL] [Abstract][Full Text] [Related]
26. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
30. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF
Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829
[TBL] [Abstract][Full Text] [Related]
31. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
32. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
Rong S; Oskarsson M; Faletto D; Tsarfaty I; Resau JH; Nakamura T; Rosen E; Hopkins RF; Vande Woude GF
Cell Growth Differ; 1993 Jul; 4(7):563-9. PubMed ID: 8398896
[TBL] [Abstract][Full Text] [Related]
34. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
[TBL] [Abstract][Full Text] [Related]
35. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
[TBL] [Abstract][Full Text] [Related]
36. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells.
Kaji M; Yonemura Y; Harada S; Liu X; Terada I; Yamamoto H
Cancer Gene Ther; 1996; 3(6):393-404. PubMed ID: 8988842
[TBL] [Abstract][Full Text] [Related]
37. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
38. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
[TBL] [Abstract][Full Text] [Related]
39. [Autocrine expression of hepatocyte growth factor and its cytoprotective effect on hepatocyte poisoning].
He Y; Zhou J; Dou K
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):275-8. PubMed ID: 11953179
[TBL] [Abstract][Full Text] [Related]
40. Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection.
Johnson M; Koukoulis G; Kochhar K; Kubo C; Nakamura T; Iyer A
Cancer Lett; 1995 Sep; 96(1):37-48. PubMed ID: 7553606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]